Ventolinhfa Hfa

Ventolinhfa Hfa

Ventolinhfa Hfa Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

VENTOLIN HFA is a beta2-adrenergic agonist indicated for:

•Treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease. (1.1)•Prevention of exercise-induced bronchospasm in patients 4 years of age and older. (1.2)

 

VENTOLIN® HFA is indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease.

 

VENTOLIN HFA is indicated for the prevention of exercise-induced bronchospasm in patients 4 years of age and older.

 

History

There is currently no drug history available for this drug.

Other Information

The active component of VENTOLIN HFA is albuterol sulfate, USP, the racemic form of albuterol and a relatively selective beta2-adrenergic bronchodilator. Albuterol sulfate has the chemical name α1-[(tert-butylamino)methyl]-4-hydroxy-m-xylene-α, α′-diol sulfate (2:1)(salt) and the following chemical structure:

MM1

Albuterol sulfate is a white crystalline powder with a molecular weight of 576.7, and the empirical formula is (C13H21NO3)2•H2SO4. It is soluble in water and slightly soluble in ethanol.

The World Health Organization recommended name for albuterol base is salbutamol.

VENTOLIN HFA is a pressurized metered-dose aerosol unit fitted with a counter. VENTOLIN HFA is intended for oral inhalation only. Each unit contains a microcrystalline suspension of albuterol sulfate in propellant HFA-134a (1,1,1,2-tetrafluoroethane). It contains no other excipients.

Priming VENTOLIN HFA is essential to ensure appropriate albuterol content in each actuation. To prime the inhaler, release 4 sprays into the air away from the face, shaking well before each spray. The inhaler should be primed before using it for the first time, when it has not been used for more than 2 weeks, or when it has been dropped.

After priming, each actuation of the inhaler delivers 120 mcg of albuterol sulfate, USP in 75 mg of suspension from the valve and 108 mcg of albuterol sulfate, USP from the mouthpiece (equivalent to 90 mcg of albuterol base from the mouthpiece).

Each 18-g canister provides 200 inhalations. Each 8-g canister provides 60 inhalations.

This product does not contain chlorofluorocarbons (CFCs) as the propellant.

 

Ventolinhfa Hfa Manufacturers


  • Remedyrepack Inc.
    Ventolinhfa Hfa (Albuterol Sulfate) Aerosol, Metered [Remedyrepack Inc. ]
  • Remedyrepack Inc.
    Ventolinhfa Hfa (Albuterol Sulfate) Aerosol, Metered [Remedyrepack Inc. ]
  • Remedyrepack Inc.
    Ventolinhfa Hfa (Albuterol Sulfate) Aerosol, Metered [Remedyrepack Inc. ]
  • Remedyrepack Inc.
    Ventolinhfa Hfa (Albuterol Sulfate) Aerosol, Metered [Remedyrepack Inc. ]
  • Remedyrepack Inc.
    Ventolinhfa Hfa (Albuterol Sulfate) Aerosol, Metered [Remedyrepack Inc. ]

Login To Your Free Account